Convenient once-daily dosing1
It's important to initiate therapy correctly to help your patients get started with appropriate supply.
Write 2 prescriptions:
Start patients on 14 days on Qsymia 3.75 mg/23 mg1
Followed by 30 days on the recommended dose of Qsymia 7.5 mg/46 mg1
12 weeks after escalating to the top dose:
If weight loss is less than 5%, discontinue treatment.1
Taper Qsymia 15 mg/92 mg gradually. Require 1 dose every other day for at least 1 week prior to stopping, due to the possibility of precipitating a seizure with abrupt cessation.1
In patients with moderate hepatic impairment or moderate/severe renal impairment, the maximum dose should not exceed the recommended dose (7.5 mg/46 mg).
The suggested follow-up is 2—8 weeks.
For more information, see the Prescriber Dosing and Management Checklist.
Counsel patients at each visit to:
Consistently use contraception to avoid pregnancy because of the increased risk of teratogenicity, if she is a female of reproductive potential. Refer these patients to the Risk of Birth Defects with Qsymia patient brochure
Modify their lifestyle, eat properly, and engage in regular physical activity
Not share Qsymia with anyone else
Report any symptoms of concern
Locate a Qsymia-certified retail pharmacy
Instruct your patients to visit www.findqsymia.com to locate a Qsymia-certified retail pharmacy.